PROBING THE MULTIPLE INTERACTIONS OF RETINOID RECEPTORS

探索类维生素A受体的多重相互作用

基本信息

  • 批准号:
    6350180
  • 负责人:
  • 金额:
    $ 23.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-09-30 至 2004-01-31
  • 项目状态:
    已结题

项目摘要

Retinoids play key roles in regulating cell proliferation and differentiation and are used as therapeutic agents in clinical settings ranging from dermatological disorders to cancer. Signaling by these hormones is mediated by two classes of ligand-activated transcription factors, the retinoic acid- and the retinoid X-receptors (RAR and RXR), which are activated by all trans- and 9 cis-retinoic acids, respectively (RA and 9cra). Because of its unique ability to heterodimerize with other nuclear receptors, RCR is involved in multiple signaling pathways and is thus sometimes termed a 'master regulator'. RXR is also unique in that, in the absence of 9cRA, it sequesters itself into transcriptionally inactive tetramers. Hence, RXR acts as an 'auto-silencer', and the first step in its activation seems to compromise ligand-induced dissociation of tetramers into active dimers and monomers. This application proposes to delineate the roles of the oligomerization behavior of RxR and the presence of various cognate ligands in governing the distribution of RXR between the multiple molecular complexes in which it may be involved in vivo. The functional consequences of the physical-chemical properties of the various RCR-containing oligomers for the transcriptional activity of RXR in cells, and the possible functional outcomes of DNA-binding by RXR tetramers will then be explored. In addition to retinoid receptors, two intracellular binding proteins for RA (CRABP-I and CRABP-II) are known to exist. The exact roles of CRABPs in the biology of RA and the functional differences between the two isoforms are not well defined. Our recent studies suggest that CRABP-II, but not CRABP-1, directly 'channels' retinoic acid to RAR, thereby enhancing the transcriptional activity of this receptor. These observations point at a novel role for CRABP-II in regulating retinoid signaling. We propose to study the CRABP-II.RAR interactions that allow for channeling of RA between them, and to address the physiological significance of these interactions by investigating the effect of CRABP-II on RA-induced stem cell differentiation. Overall, these studies are designed to clarify the factors that modulate the multiple interactions of retinoic nuclear receptors and to obtain insights into the mechanisms by which signaling by retinoids is regulated.
类维生素A在调节细胞增殖和分化中起关键作用,并在从皮肤病到癌症的临床环境中用作治疗剂。这些激素的信号传导由两类配体激活的转录因子介导,即视黄酸和类视黄酸X受体(RAR和RXR),它们分别由所有反式和9顺式视黄酸(RA和9 cra)激活。由于其与其他核受体异二聚化的独特能力,RCR参与多种信号传导途径,因此有时被称为“主调节剂”。RXR的独特之处还在于,在不存在9 cRA的情况下,它将自身隔离成转录失活的四聚体。因此,RXR作为一个“自动沉默器”,其激活的第一步似乎损害了配体诱导的四聚体解离成活性二聚体和单体。 本申请提出描述RXR的寡聚化行为和各种同源配体的存在在控制RXR在多个分子复合物之间的分布中的作用,其中RXR可能在体内参与。然后将探讨各种含RCR的寡聚体的理化性质对细胞中RXR转录活性的功能后果,以及RXR四聚体与DNA结合的可能功能结果。除了类维生素A受体,已知存在两种RA的细胞内结合蛋白(CRABP-I和CRABP-II)。CRABPs在RA生物学中的确切作用以及两种亚型之间的功能差异尚未明确。我们最近的研究表明,CRABP-II,而不是CRABP-1,直接“通道”视黄酸RAR,从而增强这种受体的转录活性。这些观察结果指出了CRABP-II在调节类维生素A信号传导中的新作用。我们建议研究的CRABP-II.RAR的相互作用,使通道之间的RA,并解决这些相互作用的生理意义,通过调查的影响,CRABP-II RA诱导的干细胞分化。总体而言,这些研究旨在阐明调节维甲酸核受体的多种相互作用的因素,并深入了解类维生素A调节信号传导的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NOA NOY其他文献

NOA NOY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NOA NOY', 18)}}的其他基金

Transcriptional Signaling by vitamin A
维生素 A 的转录信号传导
  • 批准号:
    8993280
  • 财政年份:
    2014
  • 资助金额:
    $ 23.44万
  • 项目类别:
Retinoic acid and CRABP-II in regulation of post transcriptional gene silencing
视黄酸和 CRABP-II 在转录后基因沉默调控中的作用
  • 批准号:
    8435941
  • 财政年份:
    2013
  • 资助金额:
    $ 23.44万
  • 项目类别:
Retinoic acid and CRABP-II in regulation of post transcriptional gene silencing
视黄酸和 CRABP-II 在转录后基因沉默调控中的作用
  • 批准号:
    8788507
  • 财政年份:
    2013
  • 资助金额:
    $ 23.44万
  • 项目类别:
Retinoic acid and CRABP-II in regulation of post transcriptional gene silencing
视黄酸和 CRABP-II 在转录后基因沉默调控中的作用
  • 批准号:
    8595302
  • 财政年份:
    2013
  • 资助金额:
    $ 23.44万
  • 项目类别:
Transcriptional signalling by vitamin A
维生素 A 的转录信号传导
  • 批准号:
    7929312
  • 财政年份:
    2010
  • 资助金额:
    $ 23.44万
  • 项目类别:
2010 FASEB Conference on the Retinoids
2010 年 FASEB 类视黄醇会议
  • 批准号:
    7911332
  • 财政年份:
    2010
  • 资助金额:
    $ 23.44万
  • 项目类别:
Training Programs in Cancer Pharmacology
癌症药理学培训项目
  • 批准号:
    7860070
  • 财政年份:
    2010
  • 资助金额:
    $ 23.44万
  • 项目类别:
Training Programs in Cancer Pharmacology
癌症药理学培训项目
  • 批准号:
    8092772
  • 财政年份:
    2010
  • 资助金额:
    $ 23.44万
  • 项目类别:
Training Programs in Cancer Pharmacology
癌症药理学培训项目
  • 批准号:
    8545706
  • 财政年份:
    2010
  • 资助金额:
    $ 23.44万
  • 项目类别:
Transcriptional signalling by vitamin A
维生素 A 的转录信号传导
  • 批准号:
    8308682
  • 财政年份:
    2010
  • 资助金额:
    $ 23.44万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了